Catalyst Wire Dossier Catalyst Wire Dossier

Codeine Phosphate/Guaifenesin ER Tablet 30 mg/600 mg

Codeine phosphate; guaifenesin, extended-release · Nexgen Pharma, Inc
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Codeine Phosphate/Guaifenesin ER Tablet 30 mg/600 mg, covering 2017-03-29 to 2017-03-29. Get the full timeline:

Most recent: Clinical Trial Update: Codeine Phosphate/Guaifenesin ER Tablet 30 mg/600 mg Steady State Clinical Study [Phase 1]

See pricing